Drug Repurposing
portes grátis
Drug Repurposing
Cavalla, David
Royal Society of Chemistry
02/2022
350
Dura
Inglês
9781788019033
15 a 20 dias
666
Descrição não disponível.
Introduction and Historical Overview of Drug Repurposing Opportunities;
Role of Academia: Drug Repurposing to Induce Autophagy for Treatment of Neurodegenerative Diseases;
The Role of Clinical Medicine;
Role of Industry;
Collaboration Models for Repurposing;
Screening Technologies;
Cheminformatics Data Mining and Modeling for Drug Repurposing;
Using Artificial Intelligence for Drug Repurposing;
Field Discoveries (Case Reports);
Preclinical. A Repurposed Novel Lyn Kinase Activator, MLR-1023, is a Model Example of Pharmacological Pleiotropy;
Harnessing the Potential of Early Access: Advancing Timely Patient Access to Innovative Medicines in a Sustainable Way;
Adapting Payers' and Producers' Incentives to Drug Repurposing;
Intellectual Property Considerations;
Regulatory Considerations and Strategies for Drug Repositioning;
Future Perspectives in Drug Repurposing
Role of Academia: Drug Repurposing to Induce Autophagy for Treatment of Neurodegenerative Diseases;
The Role of Clinical Medicine;
Role of Industry;
Collaboration Models for Repurposing;
Screening Technologies;
Cheminformatics Data Mining and Modeling for Drug Repurposing;
Using Artificial Intelligence for Drug Repurposing;
Field Discoveries (Case Reports);
Preclinical. A Repurposed Novel Lyn Kinase Activator, MLR-1023, is a Model Example of Pharmacological Pleiotropy;
Harnessing the Potential of Early Access: Advancing Timely Patient Access to Innovative Medicines in a Sustainable Way;
Adapting Payers' and Producers' Incentives to Drug Repurposing;
Intellectual Property Considerations;
Regulatory Considerations and Strategies for Drug Repositioning;
Future Perspectives in Drug Repurposing
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Pharmacology; Biotechnology; Organic chemistry
Introduction and Historical Overview of Drug Repurposing Opportunities;
Role of Academia: Drug Repurposing to Induce Autophagy for Treatment of Neurodegenerative Diseases;
The Role of Clinical Medicine;
Role of Industry;
Collaboration Models for Repurposing;
Screening Technologies;
Cheminformatics Data Mining and Modeling for Drug Repurposing;
Using Artificial Intelligence for Drug Repurposing;
Field Discoveries (Case Reports);
Preclinical. A Repurposed Novel Lyn Kinase Activator, MLR-1023, is a Model Example of Pharmacological Pleiotropy;
Harnessing the Potential of Early Access: Advancing Timely Patient Access to Innovative Medicines in a Sustainable Way;
Adapting Payers' and Producers' Incentives to Drug Repurposing;
Intellectual Property Considerations;
Regulatory Considerations and Strategies for Drug Repositioning;
Future Perspectives in Drug Repurposing
Role of Academia: Drug Repurposing to Induce Autophagy for Treatment of Neurodegenerative Diseases;
The Role of Clinical Medicine;
Role of Industry;
Collaboration Models for Repurposing;
Screening Technologies;
Cheminformatics Data Mining and Modeling for Drug Repurposing;
Using Artificial Intelligence for Drug Repurposing;
Field Discoveries (Case Reports);
Preclinical. A Repurposed Novel Lyn Kinase Activator, MLR-1023, is a Model Example of Pharmacological Pleiotropy;
Harnessing the Potential of Early Access: Advancing Timely Patient Access to Innovative Medicines in a Sustainable Way;
Adapting Payers' and Producers' Incentives to Drug Repurposing;
Intellectual Property Considerations;
Regulatory Considerations and Strategies for Drug Repositioning;
Future Perspectives in Drug Repurposing
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
